AIFinancial Timesabout 4 hours ago
Insilico and SK Biopharm $2.5B AI Drug Deal
1 min read
Insilico Medicine and SK Biopharmaceuticals achieved an AI-powered drug discovery collaboration worth up to $2.5 billion for neuroimmune disorders. The partnership targets the development of new treatments using artificial intelligence. The deal was announced by the companies.
Level
Hype check
Tap to vote and see what everyone thinks.
